CPAC Lab holiday fun!!

Our research advocating for 2-1-1-1 on-demand PrEP for cisgender women was featured in @BodyPROHIV! Check out Mackenzie Cottrell's interview with commentary from Jenell Stewart @HennepinHC discussing this "exciting step in the right direction" 🔗 https://t.co/2NW1b99aag

New from our lab! Adding a 4th day to the on-demand PrEP regimen may boost HIV protection for cisgender women, according to new modeling research. https://t.co/VYpiPHvr0C #HIVPrevention #PrEP #WomensHealth #UNCPharmacy

🎉 Happy to share that Eli Rosen was awarded an R01! This collaboration with OHSU will benchmark PK for both long-acting and daily ARVs in rhesus macaques and examine how pre-treatment immunopathogenic damage affects ARV tissue penetration https://t.co/Br3Ky31lfq #HIVResearch

Our collaboration with University of Colorado compares direct vs. indirect DBS assays for HIV PrEP adherence. We offer guidance for clinical interpretation, including adjustments for sample degradation outside cold-chain. 🔗 https://t.co/mduj0dLVM2 #HIVPrevention #PrEP

Antiretrovirals don’t reach all genital tissues equally—some areas may be underprotected. New imaging from a collaboration with our laboratory reveals why this matters for prevention and cure. #HIVresearch #ARVs #HIVprevention https://t.co/lRSMHXdf78

New guidelines from a collaboration with our laboratory improve how we read PrEP drug levels in blood spots—helping ensure people get the protection they need. #HIVprevention #PrEP #Adherence https://t.co/tUrDGkMhXm

The HIV PDR is revolutionizing how HIV drug data is shared—making decades of research searchable, standardized, and ready to power the next breakthroughs in treatment and prevention. #HIVresearch #DataSharing Check out our publication here 👉

#CROI2025 was fantastic! We are incredibly proud of Mackenzie Cottrell and her well-received oral presentation, "Optimizing On-Demand Tenofovir Disoproxil Fumarate/Emtricitabine Dosing in Women for HIV Prevention", which is featured on NATAP! https://t.co/a6lSKo7KWB

Check out our upcoming abstract presentation when you're at #ASCPT2025!! A Modeling Approach to Expedite the Development of a New Long-Acting Controlled-Release Multipurpose Formulation Containing Medroxyprogesterone Acetate

📊Long-Acting Injectable CAB/MPA MPT Implant for Prevention of HIV and Unintended Pregnancy

📊Dose-Ranging Pharmacokinetics and Efficacy of a 90-Day Multipurpose IVR Delivering Islatravir 📊Effect of Antiretroviral Regimen on Contraceptive Failure Among Women Using Injectable Contraception

📊A Biodegradable Implant Releasing Low-Dose Islatravir Protects Macaques From Rectal SHIV Infection 📊Combination of eCD4-IgG1 Delivered by AAV9 and AZD5582 in SIV-Infected, ART-Suppressed Infant RM

🎙️Optimizing On-Demand Tenofovir Disoproxil Fumarate/Emtricitabine Dosing in Women for HIV Prevention 🎙️An Injectable Multipurpose Implant With CAB and MPA for Long-Acting HIV Prevention and Contraception 🎙️AZD5582 and Venetoclax Reduce SIV Reservoirs in ART-Suppressed Macaques

We are authors on 8 abstracts at #CROI2025!! Titles for 3 oral 🎙️ and 5 poster 📊 presentations are below

Already looking forward to next year's International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs! Enduring materials from this year's conference available here: https://t.co/uHZiNvulZA

Excited to announce our work was nominated for the 2024 Charles C. Shepard Science Awards @CDC! https://t.co/sJ1v5cJ16i

Three papers from our lab for your weekend read! 📚 https://t.co/lew0QkWo86 https://t.co/G2kUmWZPBc https://t.co/MKpCR5ydl8

We are so proud of Mackenzie Cottrell for her promotion to Associate Professor @UNCPharmacy!! Check out her published works here 👉 https://t.co/PMNBtHr1zQ

Congratulations @AKashubaUNC for this well-deserved award!!